NO860012L - Preparater med forsinket virkning, fremgangsmaate til deres fremstilling samt tilsvarende middel til human- resp. veterinaermedisinsk anvendelse. - Google Patents

Preparater med forsinket virkning, fremgangsmaate til deres fremstilling samt tilsvarende middel til human- resp. veterinaermedisinsk anvendelse.

Info

Publication number
NO860012L
NO860012L NO860012A NO860012A NO860012L NO 860012 L NO860012 L NO 860012L NO 860012 A NO860012 A NO 860012A NO 860012 A NO860012 A NO 860012A NO 860012 L NO860012 L NO 860012L
Authority
NO
Norway
Prior art keywords
agent
preparation
preparations
gelling agent
means according
Prior art date
Application number
NO860012A
Other languages
English (en)
Norwegian (no)
Inventor
Ulrich Grau
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO860012L publication Critical patent/NO860012L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO860012A 1985-01-05 1986-01-03 Preparater med forsinket virkning, fremgangsmaate til deres fremstilling samt tilsvarende middel til human- resp. veterinaermedisinsk anvendelse. NO860012L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853500268 DE3500268A1 (de) 1985-01-05 1985-01-05 Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung

Publications (1)

Publication Number Publication Date
NO860012L true NO860012L (no) 1986-07-07

Family

ID=6259341

Family Applications (1)

Application Number Title Priority Date Filing Date
NO860012A NO860012L (no) 1985-01-05 1986-01-03 Preparater med forsinket virkning, fremgangsmaate til deres fremstilling samt tilsvarende middel til human- resp. veterinaermedisinsk anvendelse.

Country Status (14)

Country Link
EP (1) EP0187361A3 (da)
JP (1) JPS61165331A (da)
AU (1) AU586847B2 (da)
DE (1) DE3500268A1 (da)
DK (1) DK2086A (da)
ES (1) ES8703742A1 (da)
FI (1) FI860014A7 (da)
GR (1) GR860009B (da)
HU (1) HU200422B (da)
NO (1) NO860012L (da)
NZ (1) NZ214686A (da)
PH (1) PH22455A (da)
PT (1) PT81782B (da)
ZA (1) ZA8632B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2661040A (en) * 1949-10-19 1953-12-01 Guldenring Paul Meat grinder
JPH0657658B2 (ja) * 1985-04-11 1994-08-03 住友製薬株式会社 徐放性製剤
EP0193917A3 (en) * 1985-03-06 1987-09-23 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration
DE3687255T2 (de) * 1985-09-10 1993-05-06 Eisai Co Ltd Einen gewebe-plasminogen-aktivator enthaltende zusammensetzung.
DE3626908A1 (de) * 1986-08-08 1988-02-11 Bayer Ag Parenterale loesung
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
KR0131330B1 (ko) * 1987-07-01 1998-04-17 맥스 디. 헨슬레이 피브린 침착 또는 유착을 방지하기 위한 방법 및 치료 조성물
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
SE529040C2 (sv) * 2006-01-18 2007-04-17 Bows Pharmaceuticals Ag Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin
DE102007047040A1 (de) 2007-10-01 2009-04-16 Fresenius Kabi Deutschland Gmbh Transparentes Kältegel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US393264A (en) * 1888-11-20 Sash-holdefl
US3329574A (en) * 1965-04-12 1967-07-04 Schwarz Biores Inc Method and material for selective diffusion
DE2512943A1 (de) * 1974-04-02 1975-10-16 Sandoz Ag Verfahren zur herstellung protrahiert wirksamer injektionspraeparate
US3932624A (en) * 1974-06-17 1976-01-13 Morton-Norwich Products, Inc. Method for prolonging the inhibitory effect of saralasin on angiotensin II
AU513400B2 (en) * 1976-03-04 1980-11-27 Commonwealth Serum Laboratories Commission Biodegradable, sustained release composition
DE3124981A1 (de) * 1981-06-25 1983-01-13 Dr. Ruhland Nachfolger GmbH, 8425 Neustadt Wirkstoffhaltige kollageneinlage zum einfuehren in knochen oder weichteile und verfahren zu deren herstellung
JPS58206513A (ja) * 1982-05-28 1983-12-01 Eisai Co Ltd セクレチン吸着防止組成物および方法

Also Published As

Publication number Publication date
FI860014A0 (fi) 1986-01-02
EP0187361A2 (de) 1986-07-16
AU586847B2 (en) 1989-07-27
JPS61165331A (ja) 1986-07-26
GR860009B (en) 1986-04-25
ES550648A0 (es) 1987-03-01
EP0187361A3 (de) 1987-10-21
DK2086D0 (da) 1986-01-03
HU200422B (en) 1990-06-28
HUT39363A (en) 1986-09-29
ZA8632B (en) 1986-08-27
FI860014L (fi) 1986-07-06
DK2086A (da) 1986-07-06
ES8703742A1 (es) 1987-03-01
AU5183786A (en) 1986-07-10
PH22455A (en) 1988-09-12
FI860014A7 (fi) 1986-07-06
NZ214686A (en) 1989-02-24
PT81782B (pt) 1988-02-17
PT81782A (de) 1986-02-01
DE3500268A1 (de) 1986-07-10

Similar Documents

Publication Publication Date Title
AU2017200295B2 (en) Stable formulations for parenteral injection of peptide drugs
AU734781B2 (en) Stable insulin formulations
US6896894B2 (en) Proteins stabilized with polysaccharide gums
US20100210506A1 (en) Intranasal administration of rapid acting insulin
Yu et al. In vitro and in vivo evaluation of a once-weekly formulation of an antidiabetic peptide drug exenatide in an injectable thermogel
NO326780B1 (no) Insulinformulering med forbedret stabilitet samt fremgangsmate for fremstilling av slike
WO2000072873A1 (fr) Preparations lyophilisees de hgf
JPH07502515A (ja) 成長ホルモンおよびアスパラギンを含んでなる安定化医薬製剤
JP2012532177A (ja) 熱及び振動安定性インスリン製剤
JP2012051891A (ja) 成長ホルモン製剤
NO860012L (no) Preparater med forsinket virkning, fremgangsmaate til deres fremstilling samt tilsvarende middel til human- resp. veterinaermedisinsk anvendelse.
AU2016326749A1 (en) Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
CN101912600A (zh) 改善胰岛素在溶液中稳定性的方法
EP0503583A1 (en) Composition for sustained release of erythropoietin
JPH10507182A (ja) 成長ホルモンおよびイソロイシンを含んでなる医薬製剤
JPH05331071A (ja) カルシトニン遺伝子関連ペプチド類の凍結乾燥組成物および安定化法
CN109394681B (zh) 一种含有Exendin-4 Fc融合蛋白的注射制剂
Kurtzhals How to achieve a predictable basal insulin?
US20060024346A1 (en) Stabilization of biologically active proteins with mixtures of polysaccharides and amino acid based compounds
US20170035895A1 (en) Dehydrated hydrogel inclusion complex
JP2001524360A (ja) ０．５ｍｌ未満の容量を投与するための凍結乾燥タンパク質組成物を含む１回量注射器
AU699369B2 (en) A pharmaceutical formulation comprising a growth hormone and leucine
US6022858A (en) Pharmaceutical formulation of human-growth hormone pretreated with zinc salt
US5552385A (en) Pharmaceutical formulation
US20080219951A1 (en) Stabilization of Biologically Active Proteins With Mixtures of Polysaccharides and Amino Acid Based Compounds